This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignees: Daegu-Gyeongbuk Medical Innovation Foundation, Omic Smap Inc., Pimedbio, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 10 
1 out of 1 
1 out of 1 Years Active: 2026
Title: Young-Hoon Park: Innovator in Pharmaceutical Applications
Introduction
Young-Hoon Park is an inventor based in Daegu, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. Although he currently holds no granted patents, his work is focused on innovative compounds and methods that have the potential to impact medical science.
Latest Patent Applications
Young-Hoon Park's latest patent applications include:
1. **QUINAZOLINE-2,4-DIAMINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING SAME AS ACTIVE INGREDIENT** - This application describes a compound that exhibits a high inhibitory ability on euchromatic histone-lysine N-methyltransferase 2 (EHMT2), making it a promising candidate for cancer treatment.
2. **NOVEL COMPOUND, PREPARATION METHOD THEREOF, AND USE THEREOF** - This application relates to a method for preparing a biomaterial with selectively functionalized tyrosine. The method allows for high-yield coupling of a specific compound to tyrosine, maintaining the inherent activity of the biomaterial, which can be effectively used in pharmaceutical compositions.
Conclusion
Young-Hoon Park is an emerging inventor whose work in pharmaceutical applications shows great promise for future advancements in cancer treatment. His innovative approaches and dedication to research highlight the importance of continued exploration in the field of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile